BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
BioXcel Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 1, 2019
BioXcel Therapeutics reported fiscal year 2018 executive compensation information on April 1, 2019.
In 2018, three executives at BioXcel Therapeutics received on average a compensation package of $673K, a 246% increase compared to previous year.
Average pay of disclosed executives at BioXcel Therapeutics
Vimal Mehta, Chief Executive Officer, received $702K in total, which increased by 147% compared to 2017. 60% of Mehta's compensation, or $423K, was in salary. Mehta also received $270K in bonus and $8.3K in other compensation.
Vincent O'Neill, Chief Medical Officer, received a compensation package of $663K, which increased by 632% compared to previous year. 51% of the compensation package, or $337K, was in salary.
Frank Yocca, Chief Scientific Officer, earned $654K in 2018, a 212% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 1, 2019.